Richard Barcus

Zhen Lin, Hongyu Yuan, Richard Barcus et al.

Non-human primates (NHPs) serve as critical models for understanding human brain function and neurological disorders due to their close evolutionary relationship with humans. Accurate brain tissue segmentation in NHPs is critical for understanding neurological disorders, but challenging due to the scarcity of annotated NHP brain MRI datasets, the small size of the NHP brain, the limited resolution of available imaging data and the anatomical differences between human and NHP brains. To address these challenges, we propose a novel approach utilizing STU-Net with transfer learning to leverage knowledge transferred from human brain MRI data to enhance segmentation accuracy in the NHP brain MRI, particularly when training data is limited. The combination of STU-Net and transfer learning effectively delineates complex tissue boundaries and captures fine anatomical details specific to NHP brains. Notably, our method demonstrated improvement in segmenting small subcortical structures such as putamen and thalamus that are challenging to resolve with limited spatial resolution and tissue contrast, and achieved DSC of over 0.88, IoU over 0.8 and HD95 under 7. This study introduces a robust method for multi-class brain tissue segmentation in NHPs, potentially accelerating research in evolutionary neuroscience and preclinical studies of neurological disorders relevant to human health.

Qing Lyu, Sanjeev V. Namjoshi, Emory McTyre et al.

Treatment decisions for brain metastatic disease rely on knowledge of the primary organ site, and currently made with biopsy and histology. Here we develop a novel deep learning approach for accurate non-invasive digital histology with whole-brain MRI data. Our IRB-approved single-site retrospective study was comprised of patients (n=1,399) referred for MRI treatment-planning and gamma knife radiosurgery over 21 years. Contrast-enhanced T1-weighted and T2-weighted Fluid-Attenuated Inversion Recovery brain MRI exams (n=1,582) were preprocessed and input to the proposed deep learning workflow for tumor segmentation, modality transfer, and primary site classification into one of five classes. Ten-fold cross-validation generated overall AUC of 0.878 (95%CI:0.873,0.883), lung class AUC of 0.889 (95%CI:0.883,0.895), breast class AUC of 0.873 (95%CI:0.860,0.886), melanoma class AUC of 0.852 (95%CI:0.842,0.862), renal class AUC of 0.830 (95%CI:0.809,0.851), and other class AUC of 0.822 (95%CI:0.805,0.839). These data establish that whole-brain imaging features are discriminative to allow accurate diagnosis of the primary organ site of malignancy. Our end-to-end deep radiomic approach has great potential for classifying metastatic tumor types from whole-brain MRI images. Further refinement may offer an invaluable clinical tool to expedite primary cancer site identification for precision treatment and improved outcomes.